tsx « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘tsx’

Industry Leader, Binovi Technologies $VISN.ca $BNVIF Announces Upcoming Release of Binovi Connect App $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 11:13 AM on Saturday, December 5th, 2020

Redefining the delivery of its vision based cognitive training SaaS through the launch of Binovi Connect, a web-based video conferencing app solution that leverages the Best-In-Class SaaS to provide remote telehealth capabilities.
Provides the opportunity for the Company to compete and offer care in any market in the world, hyper-scaling its growth through the optimization of its provider network (over 800 registered providers), and facilitating care to individuals from the classroom or the comfort of home.
Enables users to connect with vision care professionals focused on concussion, reading skills, athletic enhancement.
The company has invested over $6M into product development and is well positioned to take its Global Expert Network and make them available to the millions of people that need their help now.

December 5, 2020 – Toronto, New York – Binovi Technologies Corp., (TSXV:VISN ) | ( OTC:BNVIF), a leader in neuro-vision performance technology, is redefining the delivery of its vision based cognitive training SaaS through the launch of Binovi Connect, a web-based video conferencing app solution that leverages the Best-In-Class SaaS to provide remote telehealth capabilities. Binovi Connect provides the opportunity for the Company to compete and offer care in any market in the world, hyper-scaling its growth through the optimization of its provider network (over 800 registered providers), and facilitating care to individuals from the classroom or the comfort of home. Binovi Connect enables users to connect with vision care professionals focused on concussion, reading skills, athletic enhancement. The company has invested over $6M into product development and is well positioned to take its Global Expert Network and make them available to the millions of people that need their help now.

“There is a great demand for healthcare services through digital platforms, amplified by the restrictions brought on by COVID-19. Professionals are looking for evidence-based, outcome-oriented solutions that offer virtual health resources for their patients, while patients are looking for a vision care experience comparable to in-person visits. Binovi Connect will allow us to scale our reach and service offering globally,” stated Adam Cegielski, Binovi CEO.

The global telehealth user community has become increasingly dependent on agile solutions that are intuitive and reliable; ease-of-use and performance are critical qualities of video service adoption. Leading contributors to telehealth SaaS include CloudMD (TSXV:DOC) , IBM Corporation (NYSE:IBM), Cerner Corporation (NASDAQ:CERN), Intel Corporation (NASDAQ:INTC), Cisco Systems (NASDAQ:CSCO) , Medtronic PLC (NYSE:MDT) . Strategic telehealth industry partnerships and collaborations will enable providers to gain a significant edge with service offerings. The Binovi Platform resources are compatible with a variety of software and hardware support solutions. The company is expecting to launch a Beta version of the app by fiscal Q1 2021.

The company is currently targeting the 50m+ students currently enrolled in K-12 Education in North America, of which approximately 20% have undetected binocular vision problems. Binovi Connect will allow users to get the benefit of quick screening, immediate optometric evaluation, and training and therapy. Recent global events relating to COVID-19 have forced healthcare providers to re-imagine the care model with remote care as a viable solution.

“We are very excited to offer this leading solution as a standard feature to all of our relationships,” said Terry Booth, Binovi Executive Chairman. “We strive to connect users with our vast global provider network through this pandemic and beyond.”

Providing the ultimate in flexibility for both providers and users, Binovi Connect allows users to browse through the entire Binovi provider network, selecting providers that meet their medical needs, performance goals, personal preferences, budget and scheduling sessions that work with their schedule.

Binovi Connect will enable school boards —in collaboration with vision specialists— to conduct screening as part of the curriculum, identifying and addressing potential issues before they can manifest as difficulties or impairments. Binovi Connect’s goal is to link knowledgeable vision care providers with patients, broadening the reach for practitioners and improving accessibility for patients. This solution will ultimately expand upon the company’s existing SaaS offering, providing greater flexibility between in-clinic and remote care appointments.

“Binovi uses cutting-edge technology and an innovative approach to bring a telehealth solution to market, comprised of a suite of tools, including testing, training, and education for vision care providers around the world. With Binovi Connect, we are bringing all this functionality to our end users —students, athletes, vision therapy and concussion patients— mediated by our network of specialists – all remotely,” commented Sam Mithani PhD, Binovi CTO.

Binovi Connect Providers will be able to:

– Set own schedule and manage practice in one place – Expand client base by reaching out to new clients – Binovi Pro and Binovi Coach integration and compatibility – Access Binovi Academy eLearning content – Conduct assessments, capture activity data, and therapy / training exercises remotely – Offer one-on-one or group sessions to reach even more people! – Collaborate with other specialists to provide the best testing, training, and treatment possible – Capture and review diagnostic, training, and milestone data on each user

Binovi Connect users will be able to:

– Easily schedule vision training and vision therapy to fit their schedule – Get vision care and training from the comfort of home – Save time —and money— with an array of options from different providers – Get the best possible care from collaborating specialists all in one place – Work with world-renowned experts in their field, regardless of location or time-zone – Learn about the various aspects of your visual system with eLearning options – Meet face-to-face without the need for travel – Own their data – Be in control of vision performance, from start to finish

For additional information on the Binovi Connect App, please visit https://binovi.com/binovi-connect/

@BinoviVISN – Twitter & Instagram

Disclaimer:

This report is strictly for information purposes only and is neither soliciting you to buy nor sell securities. BeforeTheBulls.com (TruTap LLC) is not a registered investment advisor nor a broker-dealer. Any information, opinions, or analysis contained herein are based on sources seen as trustworthy. There is no explicit or implicit representation as to the accuracy or complete nature of its contents. The present opinions herein reflect our current estimation and are subject to change. BeforeTheBulls.com (TruTap LLC) accepts zero liability for losses arising from the investor’s use of this material. BeforeTheBulls.com (TruTap LLC) has been compensated 60k for coverage of BNVIF by Binovi Technologies Corp. this year. BeforeTheBulls.com (TruTap LLC) currently holds zero shares of this stock. BeforeTheBulls.com (TruTap LLC) or its affiliates may buy shares in the open market at any time without notice. The article contains forward-looking statements, as per the Private Securities Litigation Reform Act (PSLRA), including, but not limited to statements about manufacturing, marketing, growth, and expansion. The words “may”, “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” “project,” along with similar wording are to communicate forward-looking statements. Such forward-looking data involves important risks and uncertainties that may influence results. Readers are advised to read and carefully consider any risk indicated and explained in the profiled company’s SEC and/or other government filings. Investing in microcap securities is speculative and carries a high degree of risk. Never invest in stocks discussed on this site unless you can afford to lose your entire investment.

About Binovi Connect App

Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Sam Mithani PhD

Chief Technology Officer

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: Binovi Touch, CSE, Eli Wilson. Eye therapy, eye training, neuro-visual performance, tsx, tsx-v, Vision Care Specialists
Posted in Binovi Technologies Corp., Featured | Comments Off on Industry Leader, Binovi Technologies $VISN.ca $BNVIF Announces Upcoming Release of Binovi Connect App $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

AGORACOM Small Cap 60: PyroGenesis’ $PYR.ca Proprietary Plasma Torches: A Global Solution To Reduce GHG Emissions $RTN $NOC $UTX $DDD.ca $HPQ.ca

Posted by AGORACOM-JC at 9:36 AM on Friday, December 4th, 2020

PyroGenesis Canada Inc. (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY) is on its way to assuming a leadership role in reducing greenhouse gas emissions using its proprietary plasma torches. The company intends to leverage its success into other industries and aims to become a premier environmental company geared toward reducing greenhouse gas emissions across all their business segments.

Hub On AGORACOM / Corporate Profile

Tags: 3D Systems Corporation, drosrite, Northrop Grumman Corporation, plasma, plasma torch, powders, PUREVAP, PyroGenesis, Raytheon Company, stocks, tsx
Posted in AGORACOM Small Cap 60, All Recent Posts, Featured, PyroGenesis Canada Inc. | Comments Off on AGORACOM Small Cap 60: PyroGenesis’ $PYR.ca Proprietary Plasma Torches: A Global Solution To Reduce GHG Emissions $RTN $NOC $UTX $DDD.ca $HPQ.ca

Innocan $INNO.ca Pharma to Participate in the Lytham Partners End of Year 1×1 Conference $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 4:08 PM on Thursday, December 3rd, 2020

Announced that it was invited by one of the leading IR agencies in the U.S., Lytham Partners, to participate in its End of Year 1×1 Conference (the “Conference”) from December 7-11, 2020.
CEO Iris Bincovich will be participating on behalf of Innocan and will showcase the Company in one-on-one meetings at the Conference.

Herzliya, Israel and Calgary, Alberta–(December 3, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that it was invited by one of the leading IR agencies in the U.S., Lytham Partners, to participate in its End of Year 1×1 Conference (the “Conference”) from December 7-11, 2020. CEO Iris Bincovich will be participating on behalf of Innocan and will showcase the Company in one-on-one meetings at the Conference.

To arrange a one on one meeting, please contact Ben Shamsian of Lytham Partners at [email protected] or visit https://lythampartners.com/virtual/.

CEO Iris Bincovich states: “We are glad that Innocan was selected by Lytham Partners to participate in this important conference. This invitation outlines that we are on a promising path within our field of scientific work in combining CBD with liposomes and exosomes, to target serious diseases like Epilepsy, Alzheimer or Covid-19.”

About Innocan

The Company is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD“). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. The Company plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Tags: CBD Derma Cosmetics, CBD stocks, CSE, Innocan, Relief & Go Pain Relief Spray, small cap, smallcap stocks, stocks, tsx
Posted in Innocan Pharma Corporation | Comments Off on Innocan $INNO.ca Pharma to Participate in the Lytham Partners End of Year 1×1 Conference $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

House Gets Ready For Historic Vote On Federal Marijuana Prohibition SPONSOR Harborside $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 1:03 PM on Thursday, December 3rd, 2020

SPONSOR: Harborside is a California-focused, vertically integrated, fully licensed cannabis company with its business consisting of three primary segments, Retail Dispensaries, Cultivation and Processing and Wholesale Sales (including branded product sales). Harborside operates the only drive through dispensary in California

This week the U.S. House of Representatives is expected to vote on a bill that would remove marijuana from the Controlled Substances Act and require federal courts to expunge many prior marijuana offenses. It will be the first time the full House will vote on ending the federal prohibition of cannabis.

Morgan Fox with the National Cannabis Industry Association says House passage would “send a really strong message to not only the rest of Congress, but to a lot of other states that the time to end prohibition has come.”

The Marijuana Opportunity Reinvestment and Expungement Act (MORE Act), introduced by Rep. Jerry Nadler (D., N.Y.), would eliminate conflict between state and federal law and allow states to set their own marijuana policies.

“We don’t need to have one size fits all. We just need to get rid of prohibition and then let the states do what the states are doing. It’s essentially what the states have done already. They haven’t waited for the federal government, which is why we have a lot of these discrepancies and challenges,” said Rep. Earl Blumenauer (D., Ore.), who has long pushed for marijuana legalization.

Blumenauer and Rep. Barbara Lee (D., Calif.) — who also wrote parts of the legislation — told Yahoo Finance the bill is a racial justice issue.

“It’s coming at a time when Americans are recognizing how hopelessly flawed the criminal justice system is,” said Blumenauer.

‘You’ve got to repair the damage’

The MORE Act would impose a 5% sales tax on marijuana and marijuana products. The revenue would go toward a new trust fund for grant programs designed to help people “adversely impacted by the War on Drugs” access job training, re-entry services, legal aid, treatment and more. The bill would also provide protections prohibiting denial of federal benefits based on use, possession or conviction for a marijuana offense.

“Regardless of who you are, if you’ve been incarcerated and if you’ve done your time and you get out, you should be provided for a second chance,” Lee told Yahoo Finance. “When you’ve been incarcerated or when you have have a record based on unjust laws — they’re really targeted in many ways, Black and Brown people — then you’ve got to make restitution, you’ve got to repair the damage. This fund is about the time that was lost because of barriers to employment, because of incarceration.”

The MORE Act would open up more opportunities for marijuana businesses, including access to Small Business Administration funding. It would also require the Bureau of Labor Statistics to gather demographic data on cannabis business owners and employees to ensure people of color and economically disadvantaged people are taking part in the industry.

“That really sets out a process for equity in the industry. This is a job-creating industry, and it also provides economic opportunities for minority-owned business owners,” said Lee.Graphic by David Foster/Yahoo Finance

The House Judiciary Committee passed the MORE Act last year 24 to 10 — Rep. Matt Gaetz (R., Fla.) and Rep. Tom McClintock (R., Calif.) were the only Republicans who voted for the bill.

In an interview with Yahoo Finance, McClintock said while he didn’t endorse marijuana, it’s clear U.S. marijuana laws have “not accomplished their goals.”

“These laws have done far more harm than good. They’ve created a violent underground economy and ruined the lives of so many young people who’ve had a youthful marijuana conviction, follow them and ruin their lives,” said McClintock.

The House was scheduled to vote on the bill in September, but Democratic leadership postponed the vote because some members in tight races worried passing the MORE Act before a stimulus package could hurt them at the polls.

Nearly a month after the election, there is still no additional coronavirus relief and many Republicans are again slamming Democrats for what they see as prioritizing the cannabis bill over coronavirus relief efforts.

Democrats have already passed two versions of the Heroes Act and argue it’s the Trump administration and Republican Senate that’s holding up stimulus talks.

SOURCE: https://finance.yahoo.com/news/house-gets-ready-for-historic-vote-on-federal-marijuana-prohibition-192829701.html

Tags: American CBD, california cannabis, Cannabis, Canopy Growth Corp, CSE, Greenhouse, Hemp, Record, Revenue, small cap, tsx
Posted in All Recent Posts, Harborside | Comments Off on House Gets Ready For Historic Vote On Federal Marijuana Prohibition SPONSOR Harborside $HBOR.ca $VFF.to $HARV.ca $ACB.to

PlantX Life Inc. $VEGA.ca $PLTXF Commences Trading on the OTC Pink Market and Announces Stock Option and Share Unit Awards $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 9:39 AM on Thursday, December 3rd, 2020

Common shares have begun trading on the OTC Pink Market under the symbol “PLTXF”
The Company will continue to trade in Canada on the Canadian Securities Exchange under the symbol “VEGA”

VANCOUVER, BC , Dec. 3, 2020 – PlantX Life Inc. (the “Company” or “PlantX “) (CSE: VEGA ) (Frankfurt: WNT1) (OTC Pink: PLTXF) is pleased to announce that its common shares (” Common Shares “) have begun trading on the OTC Pink Market under the symbol “PLTXF”. The Company will continue to trade in Canada on the Canadian Securities Exchange under the symbol “VEGA”.

Pursuant to the terms and conditions of its incentive stock option plan, PlantX has granted 1,815,000 incentive stock options (the ” Options “) to purchase Common Shares of PlantX to certain executive officers, consultants and employees of the Company. The Options are exercisable for a five (5) year period at a price of $0.70 per share. One quarter (1/4) of the Options will vest every three months from the date of grant.

As part of a new long-term incentive program to link pay to performance and align the interests of the Company’s management, directors, employees with shareholders, the Company also announces that a restricted share unit plan for eligible officers, directors, employees and consultants (the ” RSU Plan “), and a performance share unit plan for eligible employees and consultants (the ” PSU Plan “) were approved by the board of directors, subject to any regulatory approval and ratification by the Company’s shareholders at the next annual general meeting of shareholders (the ” AGM “). The Company may grant and issue PSUs or RSUs pursuant to the terms of the PSU Plan or RSU Plan respectively, however neither PSUs nor RSUs will be permitted to vest and be paid out until the PSU Plan and RSU Plan have been approved and ratified by shareholders.

Subject to the above approvals and any regulatory requirements, 3,950,000 PSUs were granted to officers, consultants and employees, and 550,000 RSUs were granted to directors of the Company.

The RSUs have a term of one (1) year of which one quarter (1/4) of the RSUs will vest every three (3) months from the date of grant. The PSUs have a term of one (1) year and will vest as to one third (1/3) every four months from the date of grant, subject to the achievement of certain performance metrics related to gross sales.

Further details regarding the PSU and RSU Plans and the grants made under such plans will be set out in the management information circular of the Company, which will be mailed to shareholders and filed on SEDAR in connection with the Company’s next AGM.

The Company website is http://investor.plantx.com/ .

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes statements regarding the receipt of shareholder approval of each of the PSU Plan and RSU Plan and the vesting and settlement of PSUs and RSUs.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: Bloombox Club Limited, clean eats, CSE, Liv Marketplace LLC, Odacité, pet food, plant based pet foods, plant-based, Plantx, stocks, tsx
Posted in PlantX Life Inc. | Comments Off on PlantX Life Inc. $VEGA.ca $PLTXF Commences Trading on the OTC Pink Market and Announces Stock Option and Share Unit Awards $BYND $TSN $CAG $FMCI $VERY $MEAT

VIDEO – Aurora Cannabis Founder, Terry Booth, Is Taking Binovi $VISN.ca $BNVIF Vision Therapy To Young Children All Over The Planet $EYPT $KALA $PTON

Posted by AGORACOM-JC at 9:14 AM on Thursday, December 3rd, 2020

http://www.smallcapepicenter.com/binovi%20square.png

Binovi Technologies (VISN:TSXV) is a Vision Therapy and Training Company that goes well beyond fixing eyes that simply can’t read letters on an eye chart. That’s what your optometrist does when they prescribe glasses.

What Binovi does is far more exciting and groundbreaking. Without getting scientific, Binovi delivers higher performing brains by optimizing the performance of your eyes. The result is a faster brain through stronger eyes, which creates quite the edge for the world’s best athletes and explains why their client list includes:

Dallas Stars (NHL)
Chicago Cubs (MLB)
Sporting KC (MLS)
Tennis Canada
Showcased During NFL Scouting Combine
Eli Wilson Goaltending – The World Leader In Hockey Goaltending Development

BUT EXECUTIVE CHAIRMAN, TERRY BOOTH, HAS A DIFFERENT AND BIGGER VISION (PARDON THE PUN) FOR BINOVI – GLOBAL CHILDREN

When Terry’s daughter was 5 years old, she developed eye problems that could only be treated by patching – something he says would be considered “barbaric” today. Terry discovered that 1 in 4 kids (not a typo) have vision problems beyond those treatable by an optometrist. This was a global, epidemic without a solution that often leads to kids losing critical learning time and self-confidence by Grade 3.

Fast Forward 30 years and Terry finally found the solution – Binovi – but not before he and his science team put CEO Adam Cegielski and the Company through the ringer. When the due diligence was complete, Terry Booth was all in with ~ $500,000 of his own money now invested, plus more from his network. Most importantly, he’s bringing his entire science, government and finance network to the table to bring Binvoi to children around the world.

Turn off NetFlix. Ignore your social media notifications. Grab your favourite beverage, call a couple of friends and watch this interview … twice.

Can’t spare enough time to stare at a screen? Take AGORACOM with you in your car or on your walk by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: Binovi Touch, CSE, Eli Wilson. Eye therapy, eye training, neuro-visual performance, tsx, tsx-v, Vision Care Specialists, vision therapy
Posted in AGORACOM Via Satellite, Binovi Technologies Corp., Featured | Comments Off on VIDEO – Aurora Cannabis Founder, Terry Booth, Is Taking Binovi $VISN.ca $BNVIF Vision Therapy To Young Children All Over The Planet $EYPT $KALA $PTON

#CBD Oil and Skin Care: What You Need To Know – SPONSOR: Avicanna $AVCN.ca $AVCNF $WEED.ca $CL.ca $HEXO.ca

Posted by AGORACOM-JC at 4:13 PM on Wednesday, December 2nd, 2020

SPONSOR: Avicanna (TSX: AVCN) (OTCQX: AVCNF) (FSE: ONN) is a Canadian vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global market place. When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Avicanna offers you exposure to the entire vertical. Learn More.

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

CBD Oil and Skin Care: What You Need To Know

Research shows that CBD oil has anti-inflammatory properties that are beneficial to skin health.
As such, CBD can be an active ingredient in skincare products that help treat or manage acne and other related breakouts. It is an ideal option for people with reactive skin.
Since CBD oil is plant-derived produce, thus, it having antioxidative abilities should not be surprising.
The antioxidants can help reduce the signs and impacts associated with aging.
The properties counteract free-radicals therein, reducing any inflammation while diminishing noticeable signs like reddish skin tone, wrinkles, and dullness.

By: Natalie Gray November 30, 2020

CBD oil is one of the active ingredients in skincare products that help to manage everything from wrinkles to acne. But is this hemp or marijuana extract as effective as touted? Does it offer any benefits, or is it marketing hype? Below are the facts about CBD gummies and CBD skincare that you need to know.

What Is CBD Oil?

CBD (cannabidiol) is a non-intoxicating compound found in hemp and marijuana plants, extracted in powder form. It is then processed with oil like coconut or olive to enhance its effectiveness as a skincare oil product.

CBD oil made for skincare will not evoke the “high” associate with its counterpart compound THC (tetrahydrocannabinol). While both CBD and THC can be found in hemp and marijuana plants, the hemp plant has a higher CBD and lower THC content than marijuana. At times the THC is so low that it not detectable during testing.

You should not mistake hemp-based CBD oil for hemp seed oil, another effective ingredient found in skincare products. At times, the two are marketed interchangeably, but the CBD oil has a high cannabidiol concentration while hemp seed oil has trace amounts or none.

The FDA regulated the name “CBD” used on products that claim to contain cannabidiol to state the same on the label. The regulated labeling is known as INCI (International Nomenclature of Cosmetic Ingredients). Therefore, products with names, such as CBD-enriched hemp seed oil, might not contain cannabidiol. You can be confident of what you buy is as specified on its label.

CBD For Acne-Prone Skin

According to research, acne is an inflammatory skin condition that could be triggered by various factors. Hence, some people can develop this inflammatory condition because of something they apply or even consume. Studies show that anything that can reduce the swelling and soothe the skin can help manage or treat acne. That is where CBD becomes an alternative solution that can fight the breakouts.

Research shows that CBD oil has anti-inflammatory properties that are beneficial to skin health. As such, CBD can be an active ingredient in skincare products that help treat or manage acne and other related breakouts. It is an ideal option for people with reactive skin.

CBD has been found to potentially lower sebum production, which is a unique quality that can help balance the sebum flow in the skin. But with this encouraging news, scientists still say that more studies are needs for conclusive findings that confirm the full extent of CBD’s benefits in skincare and overall health and wellness.

CBD Oil For Wrinkles And Anti-Aging

Since CBD oil is plant-derived produce, thus, it having antioxidative abilities should not be surprising. The antioxidants can help reduce the signs and impacts associated with aging. The properties counteract free-radicals therein, reducing any inflammation while diminishing noticeable signs like reddish skin tone, wrinkles, and dullness.

With other antioxidant-rich products in the market, it is unwise to claim that CBD is the best option out there. It is one of the many options worth considering if you are keen on finding a safe and better solution to caring for your skin.

CBD Oil For Sensitive Skin

CBD oil is claimed to have soothing compounds since it has been found to have skin-normalizing and skin-calming effects. Such properties are essential in treating and managing skin sensitivity and other related issues like inflammation, reactivity, and redness. With the skin exposed to the elements, different skin types are affected differently by environmental stressors. By applying CBD oil, its soothing mechanism will help keep the skin in check.

Source: http://theleafonline.com/c/lifestyle/2020/11/cbd-oil-and-skin-care-what-you-need-to-know/

Tags: cannabinoids, Cannabis, Canopy Growth Corp, CBD, Cresco Labs Inc, CSE, Hexo Corp, Marijuana, Medical Cannabis by Shoppers, Rho Phyto, tsx
Posted in All Recent Posts, Avicanna Inc. | Comments Off on #CBD Oil and Skin Care: What You Need To Know – SPONSOR: Avicanna $AVCN.ca $AVCNF $WEED.ca $CL.ca $HEXO.ca

#Blockchain Coalition Launches Tradable Carbon Credit Token – SPONSOR: Blockchain Foundry $BCFN.ca $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 11:14 AM on Wednesday, December 2nd, 2020

SPONSOR POST:

http://blog.agoracom.com/wp-content/uploads/2020/10/blockchain-foundry-square.png

BCFN:CSE

A leading North American blockchain development firm
Revenue for 1st 9 months of 2020 ~ $1.1M
- 113% Year Over Year Growth
- Positive Net Income
Self sustaining consulting practice with growing pipeline and potential upside from product development and commercialization
Partnered with Binance, the largest digital asset trading platform in the world, to leverage the Syscoin platform.
A Blockchain company with Real Products, Real Customers, Real Revenues and Real Income
Blockchain Foundry is a “Blockchain 2.0” company that has survived and will thrive

Hub On AGORACOM / Corporate Profile

Blockchain Coalition Launches Tradable Carbon Credit Token

Stablecoin pioneer Uphold is claiming to have launched the first tradable retail carbon token.

The Universal Protocol Alliance, a coalition of blockchain companies led by Uphold and including Bittrex Global, Ledger, Certik and Infinigold, announced the Universal Carbon (UPCO2) token Tuesday.

By: Ian Allison

Each blockchain-based UPCO2 token represents a certified measure of carbon dioxide. They can be bought and held as an investment, or burned to offset a company or individual’s carbon footprint, the group said.

A rather overloaded term, “carbon credits” can refer to both government-issued credits traded on regulated markets, and voluntary carbon offsetting where credits can help remove emissions via projects that plant trees, for instance. Blockchain technology has been touted as a way to prevent the double counting (or double spending) of carbon credits in all areas and markets.

Uphold is starting out by tokenizing voluntary carbon credits, in particular REDD credits that are of high quality, easy to understand and make up about 58% of the voluntary carbon market, explained JP Thieriot, co-founder of the UP Alliance and CEO of Uphold. Each UPCO2 Token represents one year-ton of CO2 pollution averted by a certified REDD+ project preventing rainforest loss or degradation, he said.

Based on the Ethereum ERC-20 standard, the tokens are backed by a Voluntary Carbon Unit (VCU), a digital certificate issued by international standards agency Verra, which allows certified projects to turn their greenhouse gas (GHG) reductions into tradable carbon credits.

Today, the retail market for voluntary carbon credits – via sites like TerraPass or Cool Effect – allow access, but not holding or trading, which is the important distinction, said Thieriot.

“We are the first people in the world that are making these credits accessible to retail, and holdable,” he told CoinDesk in an interview. “So there’s lots of retail sites that allow you to offset the trip you just took to New Zealand or give somebody a clever Christmas present. But they don’t allow the buying and holding for investment or speculative purposes.”

When he began looking at voluntary credits as fungible assets, Thieriot expected the prevailing “NGO mindset” was probably going to be sceptical of a project to harness a younger generation’s speculative interest.

“Actually, every single conversation we had, people totally got it. They all understood that if we can pull that trick off, it could change the world,” Thieriot said.

Voluntary carbon offsetting is also of interest to companies like Amazon and Microsoft and Nike, said Thieriot, who are no longer interested in waiting around for governments to take the lead, and have set out to neutralize their current carbon footprint, or even their entire historical footprint, by their own initiative.

Meanwhile, demand for carbon credits is set to outstrip supply by a factor of four to one in 2020, according to the World Bank. And a change in the political climate in the U.S. looks likely, with President-elect Joe Biden announcing a climate administration.

The UPCO2 tokens are to undergo a “curing process,” which amounts to a primary issuance, said Thieriot, whereby they will be made available from today on the Uphold platform.

“Initially we are going to offer it on Uphold for about four to six weeks and then Bittrex Global will light it up,” Thieriot said. “And then we’d like every exchange in the world to pick them up.”

Source: https://www.coindesk.com/blockchain-coalition-launches-tradable-carbon-credit-token

Tags: Bitcoin, Bitfarms Ltd., blockchain, CSE, ether, Galaxy Digital Holdings Ltd., GDPR, Hive Blockchain Technologies Ltd., Hut 8 Mining Corp., stocks, tsx
Posted in All Recent Posts, Blockchain Foundry Inc. | Comments Off on #Blockchain Coalition Launches Tradable Carbon Credit Token – SPONSOR: Blockchain Foundry $BCFN.ca $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Innocan $INNO.ca Reports Q3 2020 Financial Results $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 7:30 AM on Wednesday, December 2nd, 2020

The following is a summary of key balance sheet items as of September 30, 2020, as compared to figures as at December 31, 2019:

Cash and cash equivalents were C$2,393,060 as compared to C$2,569,602;
Current assets of C$3.6 million as compared to C$3.2 million;
Total assets of C$3.7 million as compared to C$3.3 million; and
Current liabilities of C$3.07 million as compared to C$1.4 million.

Herzliya, Israel and Calgary, Alberta–(December 2, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce today its financial and business results for the three and nine months period ended September 30, 2020 (the “Financial Statements“) and provide highlights and comments on these results. This news release should be read in conjunction with the Financial Statements and corresponding Management’s Discussion and Analysis available on the Company’s profile at www.sedar.com. The Company’s Financial Statements have been prepared in accordance with International Financial Reporting Standards (“IFRS“).

“This has been a milestone quarter for Innocan. After successfully completing our $5.1M financing, we have laid the groundwork for full commercialization of our CBD based products. We are completing the manufacturing process in Europe and the USA and have received regulatory approvals for marketing in Europe and the USA” stated Iris Bincovich, Chief Executive Officer of Innocan.”

Business highlights for the three months period ended September 30, 2020

On June 5, 2020, the Company announced the commencement of commercial production of its Derma CBD line in Portugal. The first product currently being manufactured is the patent pending Relief & Go Pain Relief spray.

On June 26, 2020, the Company announced the results from the first dermal clinical study of the Relief & Go and SHIR product lines. The double-blind, randomized control study assessed the tolerance degree of the Company’s CBD topical products and demonstrated the products to be non-irritating to the skin.

On July 9, 2020, the Company announced its collaboration with Recipharm, Israel (“Recipharm“) to synthesize and analyze cannabinoid loaded exosomes. Recipharm unites more than 30 facilities across 10 countries offering a range of services with a focus on two areas of operation: pharmaceutical development services and manufacturing services.

On July 13, 2020, the Company announced that it received notice from the U.S. Food and Drug Administration that Innocan’s over-the-counter Relief & Go Pain Relief spray received technical validation and approval to commence marketing in the USA. Innocan’s pain relief formulation contains a combination of magnesium oil, methyl salicylate, menthol and CBD. The Relief & Go Pain Relief spray is designed to target and relieve pain related to muscles and joints. The unique formulation is administered with a simple dose by spray, roll-on or lotion.

On August 6, 2020, the Company announced that its SHIR CBD Derma Cosmetic product line successfully passed safety assessments in accordance with European Union (EU) cosmetic regulation No. 1223/2009 and received an EU Cosmetic Product Safety Report for marketing in the European Union.

On August 11, 2020, the Company announced it entered into a manufacturing and distribution agreement (the “ESI Agreement“) with Endless Sky Incorporated (“ESI“), a large-scale Canadian cannabis extractor based in Calgary, Alberta. Under the ESI Agreement, ESI will serve as the exclusive distributor of Innocan’s CBD products in Canada under a license granted by Innocan. ESI will manufacture Innocan’s CBD products at ESI’s Health Canada licensed facility in Redvers, Saskatchewan. ESI’s manufacturing and distribution rights consist of the Relief & Go Pain Relief spray and cream and the SHIR Eye Serum, Face Cream and Night Cream. The ESI Agreement is conditional upon ESI receiving Health Canada approval no later than December 31, 2020. According to the ESI agreement, ESI shall pay Innocan a cash license fee per product as well as royalties based on net sales of the products distributed by ESI. The ESI Agreement is for a term of 12 months and will be automatically extended for additional periods of 12 months, each based on ESI achieving minimum sales targets for the previous 12-month period.

On August 19, 2020, the Company entered into a manufacture and supply agreement with GNB Swiss Investments SA to manufacture and supply GNB Swiss Investments SA products based on Innocan’s formulas, which will be distributed by GNB Swiss Investments SA under its own brand.

On August 20, 2020, the Company announced that Innocan entered into a distribution agreement (the “Cloud 9 Agreement“) with Cloud 9 Switzerland LLC (“Cloud 9“) to sell the Company’s SHIR Beauty and Relief & Go product lines in Italy and Switzerland. Under the terms of the Cloud 9 Agreement, Cloud 9 will distribute Innocan’s unique cosmetic CBD products in Italy and Switzerland on a nonexclusive basis. The Cloud 9 Agreement defines the ordering and delivery mechanisms for the products and the marketing cooperation between the parties. The parties intend to carry out the Cloud 9 Agreement immediately, following the completion of all registration and regulatory requirements in Italy and Switzerland.

On September 15, 2020, the Company announced it completed a cosmetic clinical study examining the impact of its SHIR Premium CBD Facial Serum, containing 300 mg of cannabidiol, on skin hydration.

Financial highlights for the three months period ended September 30, 2020, compared to the three months period ended September 30, 2019:

The following are financial highlights of Innocan’s operating results for the three months period ended September 30, 2020, compared to the three months period ended September 30, 2019:

Research and development expenses amounted to C$654,000 for the three months period ended September 30, 2020 compared to C$149,000 for the three months period ended September 30, 2019. The increase is primarily attributable to an increase in research expenses due to the new research agreements entered into during the nine months period ended September 30, 2020 with Yissum Research Development Company and Ramot at Tel Aviv University, along with an increase in patent application expenses.

Selling, general and administrative expenses amounted to C$902,000 for the three months period ended September 30, 2020 compared to C$1,858,000 for the three months period ended September 30, 2019. The decrease in selling, general and administrative expenses is primarily attributable to the reduction of issuance expenses.

The following is a summary of key balance sheet items as of September 30, 2020, as compared to figures as at December 31, 2019:

Cash and cash equivalents were C$2,393,060 as compared to C$2,569,602;
Current assets of C$3.6 million as compared to C$3.2 million;
Total assets of C$3.7 million as compared to C$3.3 million; and
Current liabilities of C$3.07 million as compared to C$1.4 million.

About Innocan

The Company is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD. Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

Innocan signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem, to develop a CBD drug delivery platform based on a unique controlled release liposome to be administrated by injection. Innocan plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research at the Hebrew University, to test the liposome platform on several potential indications. Innocan is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Tags: CBD Derma Cosmetics, CBD stocks, CSE, Innocan, Relief & Go Pain Relief Spray, small cap, smallcap stocks, stocks, tsx
Posted in Innocan Pharma Corporation | Comments Off on Innocan $INNO.ca Reports Q3 2020 Financial Results $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Universal PropTech Inc. $UPI.ca Names Frank Carnevale as Chief Growth Officer $SNE $MSFT $HON $SONA.ca

Posted by AGORACOM-JC at 4:24 PM on Tuesday, December 1st, 2020

Announced the appointment of Mr. Frank Carnevale as Chief Growth Officer.
Mr Carnevale is the former Chief Operating Officer of the Company, and is returning to focus on acquisitions, investments, organic growth strategies and execution to improve the overall value of the Company.
Mr. Carnevale will work closely with the CEO, Mr. Chris Hazelton, in delivering an aggressive growth program over the coming months.

Toronto, Ontario–(December 1, 2020) – Universal PropTech Inc. (TSXV: UPI) (“the Company”) is pleased to announce the appointment of Mr. Frank Carnevale as Chief Growth Officer.

Mr Carnevale is the former Chief Operating Officer of the Company, and is returning to focus on acquisitions, investments, organic growth strategies and execution to improve the overall value of the Company. Mr. Carnevale will work closely with the CEO, Mr. Chris Hazelton, in delivering an aggressive growth program over the coming months.

Mr. Carnevale is an award-winning CxO, industry thought leader, and has originated over $2.5 billion in energy transactions in regulated and unregulated energy service companies. He served as an Executive Board Member of the Energy Council of Canada from 2017 to 2019. He also served as a Board Member of the Council for Clean & Reliable Electricity, and the Ontario Energy Association.

“I see tremendous opportunities to improve the value of facilities by integrating proptech innovation with design, operations, and all in a very holistic customer-centric approach,” commented Frank Carnevale, Chief Growth Officer of Universal PropTech Inc.

“We are excited to have Frank back with us to aggressively grow our businesses,” stated Chris Hazelton, Chief Executive of Officer of Universal PropTech Inc. “He brings a unique perspective on how to take our share of the ongoing transformation in proptech and energy.”

About Universal PropTech Inc.

Universal PropTech Inc. (TSXV: UPI), conducts its operations through its wholly-owned subsidiary, VCI Controls Inc. (“VCI”), a leading supplier and integrator of proptech healthy building solutions and services. The Company is an industry leader in the development of intelligent building technology, including the integration of all building systems utilizing the latest in communications technologies and standards. VCI’s business focuses on digital controls and mechanical services, performance monitoring, and energy efficiency solutions.

With headquarters in Toronto, Universal PropTech has offices across Canada including, Halifax, Montreal, and Ottawa. For more information, visit www.universalproptech.com

Certain statements in this press release are forward-looking statements. The reader is cautioned that assumptions used in the preparation of such information, although considered reasonable by the Company at the time of preparation, may prove to be incorrect. Forward-looking statements, specifically those concerning future performance and other statements that are not historical fact, are subject to certain risks and uncertainties, and actual results may differ materially from the Company’s plans and expectations. These plans, expectations, risks and uncertainties are detailed herein and from time to time in the filings made by the Company with the TSX Venture Exchange (the “Exchange”) and securities regulators. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Trading in the securities of the Company should be considered highly speculative. All forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement.

Neither the Exchange, nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

CONTACT INFORMATION

Universal PropTech Inc.

Chris Hazelton

Chief Executive Officer

(647) 300-2957

Tags: AI, Big data, Cloud Computing, Delta-X Global Corp., investing, IOT, PropTech, small cap stocks, stocks, tsx, tsx-v
Posted in Universal PropTech Inc. | Comments Off on Universal PropTech Inc. $UPI.ca Names Frank Carnevale as Chief Growth Officer $SNE $MSFT $HON $SONA.ca